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We determined the kinetics of the reaction of human neuronal enolase and yeast enolase 1 with the
slowly-reacting chromophoric substrate D-tartronate semialdehyde phosphate (TSP), each in tris
(tris (hydroxymethyl) aminomethane) and another buffer at several Mg2+ concentrations, 50 or
100 lM, 1 mM and 30 mM. All data were biphasic, and could be satisfactorily ﬁt, assuming either
two successive ﬁrst-order reactions or two independent ﬁrst-order reactions. Higher Mg2+ concen-
trations reduce the relative magnitude of the slower reaction. The results are interpreted in terms of
a catalytically signiﬁcant interaction between the two subunits of these enzymes.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Enolase (E.C.4.2.1.11; 2-phospho-D-glycerate hydrolyase) cata-
lyzes and hence controls the ninth reaction of glycolysis, so is ubiq-
uitous in living organisms. The enzyme requires two moles of Mg2+
(the physiological cofactor) per active site [1]: ‘‘conformational”
Mg2+ enables the physiological substrate (2-PGA, 2-phospho-D-
glycerate), product (PEP, phosphoenolpyruvate) or analogues (such
as the slowly-reacting strongly bound substrate D-tartronate sem-
ialdehyde phosphate (TSP)) to bind. This in turn enables ‘‘catalytic”
Mg2+ to bind and produce catalysis [1,2].
Direct measurements of PEP production from 2-PGA are con-
ventionally done at 230 nm [2,3]; TSP is thought to enolize when
bound to enolases [4], and this reaction is often measured at
285 nm. Proton removal from carbon-2 is rate limiting with both
reactions [5,6], at least at pH values near the optimum. Hence,
the TSP reaction is thought to reﬂect the earliest stage(s) of the
physiological reaction.
Enolases are generally abundantly expressed, so are major cel-
lular proteins [7]. In addition, the enzyme in eukaryotes is ex-chemical Societies. Published by E
sphate; 2-PGA, 2-phospho-D-
ne-N,N0-bis(2-ethane sulfonic
fonic acid; tris, tris (hydroxy-
r).pressed as isozymes, two in yeast (called 1 and 2) and three in
vertebrates, called a, b and c. Enolase a is ubiquitous, found in
all cells. Enolase b is muscle-speciﬁc and the c isozyme is found
only in neurons. These enzymes, as isolated, are mixtures of het-
ero- and homodimers. We are concerned with whether or not
the subunits catalyze their reaction independently or whether
some catalytically signiﬁcant interaction between enolase subunits
occurs.
2. Materials and methods
Human neuronal enolase (with a his-tag) was expressed in E.
coli and isolated as described [8]. Speciﬁc activities were consis-
tent with those reported for samples of enzyme that were crys-
tallized (130 ± 10 DOD230/minute/DOD280). After correction [9]
for the effects of pH (6.9) and KCl concentration (0.4 M), kcat is
about 45 s1. For calculations of concentration, an extinction
coefﬁcient, obtained using the residue absorbencies of Perkins
[10] of 0.87/mg/ml and a subunit molecular weight of 48 015
were employed.
Yeast enolase 1 was also obtained as described [11]. Its speciﬁc
activity was also consistent with previously reported values [12]: a
kcat of ca. 125 s1. Enzyme assays were performed at ambient room
temperature, which varied from 21 to 24.
The ﬁnal puriﬁcation step of the enzymes is carried out in a tris
(tris (hydroxymethyl) aminomethane) buffer. For stopped-ﬂowlsevier B.V. All rights reserved.
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hydroxyethylpiperazine-N0-2-ethane sulfonic acid (HEPES), the
pooled fractions were concentrated by pervaporation, precipitated
with 75% ammonium sulfate, then the precipitate was dissolved
and dialyzed over 24–48 h against three changes of PIPES or HEPES.
Stopped-ﬂow measurements were done using the RSM-1000
(rapid-scanning module) from Olis, Inc. (Bogart, GA) at ambient
room temperature (about 22).
Reagents were AR grade; 2-PGA was from Sigma–Aldrich (St.
Louis, MO) as were HEPES and PIPES. Tris was from BioRad. TSP
was synthesized as described by Spring and Wold [13]. The very
strongly bound competitive inhibitor phosphono-acetohydroxa-
mate was prepared and assayed as described by Anderson et al.
[14].3. Results
We carried out steady-state activity measurements to delineate
the effects of various parameters on the physiological reaction (2-
PGA? PEP) catalyzed by the human neuronal enolase. Some preli-
minary enzymatic characteristics have been reported [8,15]. Acti-
vation constants for Mg2+ and Km values for 2-PGA which we
measured were in good agreement.
The effect of pH on the Vmax of the human neuronal enolase was
determined, varying the Mg2+ concentration at each pH value. An
optimum pH (corrected) [9] of 7.2–7.4 was observed (not shown),
and we used buffers at pH 7.2 and 7.5 for the stopped-ﬂow mea-
surements. The human neuronal enzyme, like yeast enolase 1, is
inhibited by Mg2+ concentrations above 1 mM [16] (also not
shown). Yeast enolase 1 has a pH optimum of 7.7 [17] and we em-
ployed HEPES–NaOH at pH 7.6 and tris–HCl at pH 7.8 for stopped-
ﬂow measurements with that enzyme.
Originally, we wished to see if Mg2+ concentrations above 1 mM
inhibited the TSP reaction; in other words, is the inhibition of the
physiological reaction due to slowing product (PEP) release
[5,18], or, a possibility suggested by Faller et al. [2], due to binding
of a third, inhibitory Mg2+ at the active site?
The TSP reaction requires catalytic Mg2+ binding [19] and can be
monitored using stopped-ﬂow measurements [20]. This is a mea-
surement of a single turnover, since the TSP enolate picks up a pro-
ton and isomerizes to the non-absorbing (over 250–320 nm) keto
form when it dissociates [4,6]. The OLIS RSM apparatus measures
the absorption spectrum of two solutions mixed rapidly (in ca.
2 ms), at 1 ms intervals thereafter. We routinely used 18–20 lM
enzyme, and the OLIS cuvette has an optical pathlength of 1 cm,
so were measuring maximum absorbencies around 280 nm of
about 0.5–0.6.
We present results of measurements made at three Mg2+ con-
centrations, 100 lM, 1 mM and 30 mM, which for the physiological
(2-PGA? PEP) reaction are below saturation, saturating and inhib-
itory, respectively [2,16]. Both the human neuronal enolase and
yeast enolase 1 interact with tris [8,21], so we used that buffer
and also two ‘‘non-interacting” buffers, PIPES and HEPES, for com-
parison. Global ﬁts were made to data collected over the wave-
length range 250–320 nm. The data were ﬁtted to various kinetic
schemes until a satisfactory ﬁt, judged from the randomness of
the absorbance residuals as functions of time after mixing, was
seen.
The reactions of several preparations of the human and yeast
enzymes and of TSP gave consistent results: all reactions could
be ﬁt only by assuming biphasic (each ﬁrst order) kinetics
(Fig. 1). The data are equally well ﬁt assuming two successive reac-
tions or two parallel ones. The data presented in Fig. 1 are repre-
sentative examples showing effects of low and high magnesium
ion concentrations and some different ﬁtting models. We presentthe kinetic and absorbance parameters from the simplest kinetic
scheme giving satisfactory ﬁts in Table 1. All parameters are means
and standard deviations of three or four replicate measurements.
We also ﬁnd that higher Mg2+ concentrations reduced the apparent
extent (DOD) of the slower reaction in absolute terms, while
increasing that of the faster.
The ‘‘30 mM” data shown in Table 1 involve mixing enolase
solutions containing 0.1 mMMg2+ with 60 mMMg2+ plus TSP solu-
tion, so there is a signiﬁcant increase in ionic strength. We also per-
formed stopped-ﬂow measurements in which yeast enolase 1 with
30 mMMg2+ present was mixed with 30 mMMg2+ plus TSP. Also,
we carried out those measurements using solutions that also con-
tained 0.15 M KCl, as this produces a small (15–20%) increase in
the rate of the physiological reaction (unpublished observations).
In addition, we carried out stopped-ﬂow measurements in which
the yeast enzyme in 30 mMMg2+ containing subsaturating levels
(0.25 and 0.5 moles per mole of active site) of TSP or the very
strongly bound competitive inhibitor phosphono-acetohydroxa-
mate [14] were mixed with 30 mMMg2+ plus TSP (not shown).
In no case did we observe single ﬁrst-order kinetics; all data were
ﬁt, assuming either two successive ﬁrst order or two parallel ﬁrst-
order reactions and the rates obtained were consistent with those
presented in Table 1.
The software supplied with the OLIS RSM enables us to recon-
struct the absorption spectra of all assumed ﬁtted species. These
are of varying magnitudes, depending on the Mg2+ concentration,
but may be normalized to a common maximum magnitude for
the sake of comparison.
These calculated difference spectra were obtained using the hu-
man neuronal enolase in tris and in PIPES. They were very similar
but the spectra obtained at 100 lMMg2+ corresponding to the
slower reaction were shifted 2–3 nm to longer wavelengths rela-
tive to those of the faster (not shown). At 30 mMMg2+, the spectra
are closer but those of the faster reaction are perhaps at 1 nm
shorter wavelengths. This suggests the Mg2+ concentration affects
the environments of the TSP enolates, but does not permit us to
distinguish between alternative kinetic models.
The two successive reaction kinetic model is applicable only if
the ﬁrst step is controlled – produced – by catalytic Mg2+ binding.
Hence, suppression of a second consecutive slower reaction by
higher Mg2+ concentrations makes no sense, since a slower second
consecutive reaction must be rate limiting. We conclude two par-
allel reactions is the more likely mechanism.
There is considerable crystallographic evidence [8,22–24] that
binding of substrate/analogues at the active sites of both enzymes
is accompanied by movement of polypeptide loops that close
around the active sites. (Since crystals are routinely prepared with
saturating levels of all ligands, it is not presently possible to say
whether substrate binding alone – no catalytic Mg2+ bound – pro-
duces any loop(s) movement, but it is plausible that some move-
ment occurs [7].) This movement is transmitted between the
subunits, producing binding of 2-PGA in one subunit and PEP in
the other [24, L. Lebioda, personal communication]. Since the TSP
enolization kinetics are always complex, we interpret our data in
terms of subunit interactions involving catalysis.
At low Mg2+ concentrations (50 or 100 lM) but high TSP con-
centrations (100 or 200 lM), some enolase molecules will have
TSP bound in both subunits but catalytic Mg2+ in only one. Our re-
sults suggest the subunit with bound TSP but no catalytic Mg2+
shows the TSP reaction in the other subunit, so that the slower
reaction contributes a larger fraction of the total absorbance
change. This is consistently observed (Table 1).
The increases in rate of the faster reaction produced by high-
er Mg2+ concentrations in PIPES or HEPES buffers could be
interpreted in terms of an anticooperative binding of catalytic
Mg2+. Stopped-ﬂow measurements of TSP enolization rates at
Fig. 1. Examples of residuals plots of attempted ﬁts to the stopped-ﬂow data from two reactions, assuming (A and D) a single ﬁrst-order reaction; (B and E) two successive
ﬁrst-order reactions: (C and F) two independent (parallel) ﬁrst-order reactions. The upper reaction (A, B and C) was of yeast enolase 1 (10 lM subunits after dilution) reacting
with 200 lM (after dilution) TSP with 30 mMMg2+ (after dilution), present. The lower reaction (D, E and F) had 50 lMMg2+ (after dilution) present. Both of these particular
reactions were performed in 0.05 ionic strength tris–HCl, pH 7.8.
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and 3 and 10 mM with the human enzyme (not shown) are
consistent with this interpretation. Evidence from steady-state
kinetics of the physiological reaction (2-PGA? PEP) obtained
using four yeast enolase) mutants (H159N, A, F and N207A),
all with changes in a residue involved in loop movement or
one participating in intersubunit interaction, suggest this [12].
However, another explanation is possible for the higher rates
observed at 30 mMMg2+. Higher Mg2+ concentrations promote
increased average closure of loops around the active sites. This
dynamic process produces a population of enolase molecules,
some with one subunit without catalytic Mg2+ bound that slows
the TSP reaction in the others subunit. So the contribution of
the slower reaction to the total is reduced but not eliminated
at 30 mMMg2+. A higher Mg2+ concentration stabilizes the
closed and more reactive subunit conformation simply by mass
action.
(The inhibition of the rate of reaction of the physiological sub-
strate by Mg2+ concentrations above 1 mM occurs because the sta-
bilized closure of the peptide loops about the active site reduces
the rate of product release [16].)
Beyond that, the effects observed of Mg2+ concentration in tris
buffers are difﬁcult to rationalize. A molecule of tris binds to thesubunit of human neuronal enolase that also binds a sulfate at
the active site [8]. There may be a synergistic relation between
TSP and tris binding at one subunit, but this is speculative.
The data also show seemingly erratic, though often signiﬁcantly
different, rates of the slower reaction at the different Mg2+ concen-
trations. Further analyses, crystallographic as well as kinetic, may
clarify these points.
4. Discussion
Lane and Hurst [20] carried out stopped-ﬂow-temperature
jump analyses in 1 mMMg2+ of the reaction of TSP and other ana-
logues with yeast enolase 1. No buffer was employed. At 4, the
reactions with TSP appeared to be ﬁrst order, though detailed anal-
ysis of the kinetics on the basis of oscilloscope tracings was not fea-
sible. Our results show how dramatically both instrumentation and
software have improved in the 30 years since then. They also con-
cluded that TSP bound rapidly but reacted more slowly. Thus, a
certain amount of time in which catalytic Mg2+ remains bound to
the enzyme–TSP complex is necessary to produce proton loss
and enolization of the TSP. This time would be within the dead
time of the stopped-ﬂow, as no lag phase has been observed by
them or by us.
Table 1
Kinetic parameters obtained from reaction of human neuronal enolase and yeast enolase 1 with TSP.
Buffer [Mg2+]ﬁnal [TSP]ﬁnal k1 (s1) k2 (s1) DA, (DOD285) DA2 (DOD285)
A. Yeast enolase
0.05 M HEPES–NaOH, pH 7.6 50 lM 100 lM 1.31 ± 0.14 0.278 ± 0.004 0.042 ± 0.001 0.070 ± 0.003
100 lM 100 lM 1.08 ± 0.11 0.339 ± 0.014 0.060 ± 0.0003 0.062 ± 0.002
100 lM 200 lM 0.81 ± 0.03 0.308 ± 0.004 0.096 ± 0.002 0.035 ± 0.002
1 mM 100 lM 1.02 ± 0.04 0.024 ± 0.008 0.145 ± 0.001 0.013 ± 0.004
30 mM 100 lM 2.94 ± 0.03 0.41 ± 0.08 0.145 ± 0.002 0.005 ± 0.0001
30 mM 200 lM 3.14 ± 0.09 0.525 ± 0.25 0.141 ± 0.003 0.008 ± 0.002
C/2 = 0.05 tris–HCl, pH 7.8 50 lM 100 lM 0.45 ± 0.04 0.060 ± 0.003 0.019 ± 0.008 0.036 ± 0.003
50 lM 200 lM 0.46 ± 0.04 0.062 ± 0.004 0.017 ± 0.0007 0.040 ± 0.0002
100 lM 100 lM 0.61 ± 0.16 0.071 ± 0.006 0.015 ± 0.0013 0.050 ± 0.002
1 mM 100 lM 0.75 ± 0.05 0.244 ± 0.027 0.062 ± 0.006 0.079 ± 0.006
30 mM 100 lM 0.92 ± 0.061 0.216 ± 0.047 0.143 ± 0.004 0.011 ± 0.005
30 mM 200 lM 1.15 ± 0.026 0.087 ± 0.011 0.154 ± 0.0004 0.007 ± 0.001
B. Human neuronal enolase
DA, (DOD291) DA2 (DOD291)
0.05 M PIPES–NaOH, pH 7.2 100 lM 100 lM 6.4 ± 1.1 1.3 ± 0.5 0.012 ± 0.010 0.059 + 0.009
1 mM 100 lM 7.7 ± 0.6 1.24 ± 0.4 0.060 ± 0.006 0.036 ± 0.004
30 mM 100 lM 13.5 ± 3.8 3.0 ± 2.2 0.050 ± 0.035 0.042 ± 0.017
C/2 = 0.05 tris–HCl, pH 7.5 100 lM 100 lM 14.1 ± 2.0 3.0 ± 0.2 0.041 ± 0.008 0.045 ± 0.005
1 mM 100 lM 20.1 ± 3.4 7.09 ± 0.8 0.042 ± 0.044 0.052 ± 0.014
30 mM 100 lM 17.0 ± 1.3 4.5 ± 0.8 0.095 ± 0.009 0.019 ± 0.006
Kinetic parameters obtained upon reaction of TSP with enolases in the stopped-ﬂow apparatus. The enzymes (18.5 or 20 lM subunits) in the buffers shown were mixed with
equal volumes of the same buffer containing D-TSP; sufﬁcient Mg2+ was present in the TSP solutions to produce the ﬁnal concentrations indicated. The parameters were
obtained, assuming two parallel reactions were occurring: A? B, C? B, and are averages and standard deviations obtained between 250 and 320 nm and 3 or 4 replicate
measurements.
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trations (30 mM) that are inhibitory to the steady-state physiolog-
ical reaction, that is, there is no evidence for binding of inhibitory
Mg2+, consistent with the interpretation of Poyner et al. [18].
X-ray crystallographic studies of the human neuronal enolase
complexed with substrate/product show no evidence of a third
equivalent of Mg2+ bound at the active sites even at free Mg2+ con-
centrations of 200 mM (L. Lebioda, personal communication).
Otherwise, the salient ﬁnding is that with both enolases, under
all conditions (buffer, pH, Mg2+ and TSP concentrations) employed
by us, the kinetics are biphasic: ﬁts using a single exponential are
not satisfactory. If the subunits reacted independently, we would
not see this.
The next most obvious result is that higher concentrations of
Mg2+ or, to some extent higher TSP concentrations, reduce the
amplitude of the slower phase. Since substrate and Mg2+ binding
are ordered and interdependent [5,18] that is equivalent to saying
that more extensive or complete saturation by catalytic Mg2+ bind-
ing produces the effect.
The observed effect of Mg2+ indicates that optical or electronic
artifacts are not a factor. It also indicates that a secondary relaxa-
tion of the initial product of TSP enolization is not the cause of the
kinetics observed; the slower reaction is not obligatory, in other
words. The observation with the human enzyme that the product
of the slower reaction has an absorption spectrum signiﬁcantly
shifted, relative to the product of the faster one, could also be ex-
plained by a difference in environment of the TSP in the two sub-
units. The crystallographic structure of human neuronal enolase
complexed with TSP shows a marked difference in the TSP bound
in the two subunits (L. Lebioda, personal communication), though
the time scale over which this difference develops is uncertain.
There is a minor controversy over whether enolase subunits
catalyze their reactions independently or whether there is some
interaction between subunits that affects their turnover. It has
been shown that yeast enolase 1 subunits dissociated in the pres-
ence of Mg2+ have some level of activity [25]. The X-ray crystallo-
graphic data show intersubunit interactions occurring through
N207 in yeast enolase 1 [11]. The N207A mutant of that enzyme
has 22% of the activity of native enolase at 1 mMMg2+, but alsoshows a biphasic Mg2+ activation, so the maximum activity of
N207A enolase, extrapolated to inﬁnite Mg2+ concentration, is
56% of native yeast enolase 1 [12], the latter assayed at 1 mMMg2+,
the normal optimal concentration.
Sims et al. [23] prepared a heterodimer of yeast enolase 1 (with
two surface residues modiﬁed to make chromatographic separa-
tion easier) and the K345A mutant, and obtained the crystal struc-
ture with bound substrate. The kcat value of the heterodimer was
35–50% of the homodimer of wild type enolase, depending on what
reference is employed. These authors also suggested the asymme-
try between yeast enolase subunits is an artifact of the crystal
packing.
However, the his-tagged human neuronal enolase crystallizes
in a different space group and also exhibits asymmetry between
subunits [8]. The data presented here use unmutated (except
for the his-tag) enzymes and are not consistent with indepen-
dently catalyzing subunits. They are easily consistent with cata-
lytically signiﬁcant interaction. We suggest a reduction of
turnover (kcat) owing to the association of enolase subunits to
about 60 ± 20% occurs. This is reasonably consistent with all these
observations. Because of the abundant expression of enolases, this
would have no physiological signiﬁcance, but results from the
generally cooperative nature of interactions producing the levels
of protein structure. Nor should this be surprising: movement
of polypeptide chains during catalysis of multisubunit enzymes
is often transmitted between subunits and may affect activity; in-
deed, complete enzymatic independence of subunits would seem
anomalous.
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